Shopping Cart
- Remove All
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $54 | In Stock | |
5 mg | $128 | In Stock | |
10 mg | $213 | In Stock | |
25 mg | $425 | In Stock | |
50 mg | $628 | In Stock | |
100 mg | $896 | In Stock | |
1 mL x 10 mM (in DMSO) | $153 | In Stock |
Description | BAY-1816032 is a potent and orally available inhibitor of bidding uninhibited by benzimidazoles 1 ( BUB1) kinase (IC50: 7 nM). |
Targets&IC50 | BUB1 kinase:7 nM |
In vitro | Mechanistically BAY-1816032 abrogates nocodazole-induced Thr-120 phosphorylation of the major BUB1 target protein histone H2A in HeLa cells (IC50: 29 nM), induced lagging chromosomes, and mitotic delay. Persistent lagging chromosomes and missegregation are observed in combination with low concentrations of paclitaxel. Single-agent BAY-1816032 inhibits the proliferation of various tumor cell lines with a median IC50 of 1.4 μM and demonstrates synergy or additivity with paclitaxel or docetaxel in almost all cell lines evaluated. |
In vivo | In tumor xenograft studies, BAY 1816032 marginally inhibits tumor growth when administered orally as a single agent. However, when combined with paclitaxel or docetaxel, it significantly and notably reduces tumor size compared to the respective monotherapy treatments. |
Molecular Weight | 534.51 |
Formula | C27H24F2N6O4 |
Cas No. | 1891087-61-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | H2O: < 0.1 mg/mL (insoluble) DMSO: 15 mg/mL (28.06 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.